• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去甲苯并吗啡烷骨架:调节西格玛受体亚型选择性的化学工具。

Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity.

作者信息

Sahn James J, Hodges Timothy R, Chan Jessica Z, Martin Stephen F

机构信息

Department of Chemistry, The University of Texas at Austin, Austin, Texas 78712, United States.

出版信息

ACS Med Chem Lett. 2017 Mar 21;8(4):455-460. doi: 10.1021/acsmedchemlett.7b00066. eCollection 2017 Apr 13.

DOI:10.1021/acsmedchemlett.7b00066
PMID:28435536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5392765/
Abstract

Some norbenzomorphans exhibit high affinity for sigma 1 and sigma 2 receptors, and varying the position of substituents on the aromatic ring of this scaffold has a significant effect on subtype selectivity. In particular, compounds bearing several different substituents at C7 of the norbenzomorphan ring system exhibit a general preference for the sigma 1 receptor, whereas the corresponding C8-substituted analogues preferentially bind at the sigma 2 receptor. These findings suggest that the norbenzomorphan scaffold may be a unique chemical template that can be easily tuned to prepare small molecules for use as tool compounds to study the specific biological effects arising from preferential binding at either sigma receptor subtype. In the absence of structural characterization data for the sigma 2 receptor, such compounds will be useful toward refining the pharmacophore model of its binding site.

摘要

一些去甲苯并吗啡烷对σ1和σ2受体表现出高亲和力,并且改变该骨架芳香环上取代基的位置对亚型选择性有显著影响。特别地,在去甲苯并吗啡烷环系统的C7位带有几个不同取代基的化合物通常对σ1受体有偏好,而相应的C8取代类似物则优先结合于σ2受体。这些发现表明,去甲苯并吗啡烷骨架可能是一种独特的化学模板,可轻松调节以制备小分子用作工具化合物,来研究优先结合任一σ受体亚型所产生的特定生物学效应。在缺乏σ2受体结构表征数据的情况下,此类化合物将有助于完善其结合位点的药效团模型。

相似文献

1
Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity.去甲苯并吗啡烷骨架:调节西格玛受体亚型选择性的化学工具。
ACS Med Chem Lett. 2017 Mar 21;8(4):455-460. doi: 10.1021/acsmedchemlett.7b00066. eCollection 2017 Apr 13.
2
Norbenzomorphan Framework as a Novel Scaffold for Generating Sigma 2 Receptor/PGRMC1 Subtype-Selective Ligands.作为一种新型骨架,诺苯吗啡烷用于生成 σ2 受体/PGRMC1 亚型选择性配体。
ChemMedChem. 2016 Mar 17;11(6):556-61. doi: 10.1002/cmdc.201500551. Epub 2016 Feb 24.
3
Structure-affinity relationships of stereoisomers of norbenzomorphan-derived σR/TMEM97 modulators.苯并吗啡烷衍生的 σR/TMEM97 调节剂立体异构体的结构-亲和力关系。
Eur J Med Chem. 2023 Sep 5;257:115488. doi: 10.1016/j.ejmech.2023.115488. Epub 2023 May 23.
4
Preparation of novel analogs of 2-arylpiperidines and evaluation of their sigma receptor binding affinities.新型 2-芳基哌啶类似物的制备及其 sigma 受体结合亲和力评估。
Eur J Med Chem. 2022 May 5;235:114310. doi: 10.1016/j.ejmech.2022.114310. Epub 2022 Mar 23.
5
Investigating isoindoline, tetrahydroisoquinoline, and tetrahydrobenzazepine scaffolds for their sigma receptor binding properties.研究异吲哚、四氢异喹啉和四氢苯并氮杂䓬骨架的 sigma 受体结合特性。
Eur J Med Chem. 2018 May 10;151:557-567. doi: 10.1016/j.ejmech.2018.02.024. Epub 2018 Mar 29.
6
Synthesis and structure-activity studies of N,N'-diarylguanidine derivatives. N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist.N,N'-二芳基胍衍生物的合成与构效关系研究。N-(1-萘基)-N'-(3-乙基苯基)-N'-甲基胍:一种新型选择性非竞争性N-甲基-D-天冬氨酸受体拮抗剂。
J Med Chem. 1994 Jan 21;37(2):260-7. doi: 10.1021/jm00028a009.
7
Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines.对σ2结合位点具有亚纳摩尔亲和力和选择性的西格玛配体。2. 螺环连接的苯并呋喃、异苯并呋喃和苯并吡喃哌啶。
J Med Chem. 1995 May 26;38(11):2009-17. doi: 10.1021/jm00011a020.
8
Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site.对σ1结合位点具有偏好性的取代苯并[d]恶唑-2(3H)-酮衍生物。
Eur J Med Chem. 2009 Jan;44(1):124-30. doi: 10.1016/j.ejmech.2008.03.011. Epub 2008 Mar 27.
9
Structure-Affinity relationships of novel σR/TMEM97 ligands.新型 σR/TMEM97 配体的结构-亲和力关系。
Bioorg Chem. 2024 Apr;145:107191. doi: 10.1016/j.bioorg.2024.107191. Epub 2024 Feb 10.
10
Muscarinic receptor binding profile of para-substituted caramiphen analogues.对位取代卡拉美芬类似物的毒蕈碱受体结合特征
J Med Chem. 1991 Oct;34(10):2984-9. doi: 10.1021/jm00114a005.

引用本文的文献

1
Recent Developments in Sigma-2 Receptor Compounds for Pain.用于疼痛治疗的西格玛-2受体化合物的最新进展
Cureus. 2024 May 8;16(5):e59882. doi: 10.7759/cureus.59882. eCollection 2024 May.
2
Highly specific σR/TMEM97 ligand FEM-1689 alleviates neuropathic pain and inhibits the integrated stress response.高度特异性 σR/TMEM97 配体 FEM-1689 可缓解神经性疼痛并抑制整合应激反应。
Proc Natl Acad Sci U S A. 2023 Dec 26;120(52):e2306090120. doi: 10.1073/pnas.2306090120. Epub 2023 Dec 20.
3
Highly specific σR/TMEM97 ligand alleviates neuropathic pain and inhibits the integrated stress response.高特异性σR/TMEM97配体可减轻神经性疼痛并抑制整合应激反应。
bioRxiv. 2023 Oct 17:2023.04.11.536439. doi: 10.1101/2023.04.11.536439.
4
σR/TMEM97 in retinal ganglion cell degeneration.σR/TMEM97 在视网膜神经节细胞变性中的作用。
Sci Rep. 2022 Dec 1;12(1):20753. doi: 10.1038/s41598-022-24537-3.
5
Neuroprotective Effects of σR/TMEM97 Receptor Modulators in the Neuronal Model of Huntington's Disease.σR/TMEM97 受体调节剂在亨廷顿病神经元模型中的神经保护作用。
ACS Chem Neurosci. 2022 Oct 5;13(19):2852-2862. doi: 10.1021/acschemneuro.2c00274. Epub 2022 Sep 15.
6
Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity.鉴定和表征 MAM03055A:一种具有细胞毒性活性的新型双价 sigma-2 受体/TMEM97 配体。
Eur J Pharmacol. 2021 Sep 5;906:174263. doi: 10.1016/j.ejphar.2021.174263. Epub 2021 Jun 16.
7
Virtual Screening for Ligand Discovery at the σ Receptor.用于在σ受体上发现配体的虚拟筛选
ACS Med Chem Lett. 2020 Jul 27;11(8):1555-1561. doi: 10.1021/acsmedchemlett.9b00314. eCollection 2020 Aug 13.
8
Development of Tetrahydroindazole-Based Potent and Selective Sigma-2 Receptor Ligands.四氢吲唑类高效且选择性 sigma-2 受体配体的开发。
ChemMedChem. 2019 Jul 3;14(13):1248-1256. doi: 10.1002/cmdc.201900203. Epub 2019 Jun 3.
9
Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands.发现一类新型强效和选择性四氢吲哚嗪为基础的sigma-1 受体配体。
Bioorg Med Chem. 2019 May 1;27(9):1824-1835. doi: 10.1016/j.bmc.2019.03.030. Epub 2019 Mar 16.
10
Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury.创伤性脑损伤后 sigma 2 受体/TMEM97 调节剂 (DKR-1677) 的神经保护作用。
ACS Chem Neurosci. 2019 Mar 20;10(3):1595-1602. doi: 10.1021/acschemneuro.8b00543. Epub 2018 Dec 3.

本文引用的文献

1
Sigma-2 receptor and progesterone receptor membrane component 1 (PGRMC1) are two different proteins: Proofs by fluorescent labeling and binding of sigma-2 receptor ligands to PGRMC1.西格玛-2受体和孕激素受体膜成分1(PGRMC1)是两种不同的蛋白质:通过荧光标记以及西格玛-2受体配体与PGRMC1的结合来证明。
Pharmacol Res. 2017 Mar;117:67-74. doi: 10.1016/j.phrs.2016.12.023. Epub 2016 Dec 19.
2
Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease.σ2受体的小分子调节剂具有神经保护作用,并可减轻阿尔茨海默病实验模型中的认知缺陷和神经炎症。
J Neurochem. 2017 Feb;140(4):561-575. doi: 10.1111/jnc.13917.
3
Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy.新型烷氧基异恶唑作为具有抗伤害感受功效的σ-1受体拮抗剂的研发
J Med Chem. 2016 Jul 14;59(13):6329-43. doi: 10.1021/acs.jmedchem.6b00571. Epub 2016 Jun 30.
4
Crystal structure of the human σ1 receptor.人类σ1受体的晶体结构。
Nature. 2016 Apr 28;532(7600):527-30. doi: 10.1038/nature17391. Epub 2016 Apr 4.
5
Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance.PGRMC1/西格玛-2受体的血红素依赖性二聚化促进癌症增殖和化疗耐药性。
Nat Commun. 2016 Mar 18;7:11030. doi: 10.1038/ncomms11030.
6
Norbenzomorphan Framework as a Novel Scaffold for Generating Sigma 2 Receptor/PGRMC1 Subtype-Selective Ligands.作为一种新型骨架,诺苯吗啡烷用于生成 σ2 受体/PGRMC1 亚型选择性配体。
ChemMedChem. 2016 Mar 17;11(6):556-61. doi: 10.1002/cmdc.201500551. Epub 2016 Feb 24.
7
The Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 are Different Binding Sites Derived From Independent Genes.Sigma-2 受体和孕激素受体膜成分 1 是源自不同基因的不同结合位点。
EBioMedicine. 2015 Oct 19;2(11):1806-13. doi: 10.1016/j.ebiom.2015.10.017. eCollection 2015 Nov.
8
The PGRMC1 Protein Level Correlates with the Binding Activity of a Sigma-2 Fluorescent Probe (SW120) in Rat Brain Cells.PGRMC1蛋白水平与大鼠脑细胞中一种西格玛-2荧光探针(SW120)的结合活性相关。
Mol Imaging Biol. 2016 Apr;18(2):172-9. doi: 10.1007/s11307-015-0891-z.
9
Investigational sigma-1 receptor antagonists for the treatment of pain.用于治疗疼痛的研究中的 sigma-1 受体拮抗剂。
Expert Opin Investig Drugs. 2015;24(7):883-96. doi: 10.1517/13543784.2015.1048334. Epub 2015 Jun 3.
10
Elements in support of the 'non-identity' of the PGRMC1 protein with the σ2 receptor.支持 PGRMC1 蛋白与 σ2 受体非同一性的元素。
Eur J Pharmacol. 2015 Jul 5;758:16-23. doi: 10.1016/j.ejphar.2015.03.067. Epub 2015 Apr 3.